Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Express Scripts (ESRX)

73.49 -0.27 (-0.37%)

04-20 16:00

Open:

73.83

Pre. Close:

74.74

High:

74.08

Low:

72.39

Volume:

1,798,065

Market Cap:

41267M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

74.156 - 74.561

74.561 - 74.897

Low:

71.403 - 71.911

71.911 - 72.332

Close:

72.718 - 73.5

73.5 - 74.149

Technical analysis  (as of: 2018-04-20 4:29:26 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 89.83     One year: 104.92

Support:

Support1: 70.74    Support2: 66.93

Resistance:

Resistance1: 76.91    Resistance2: 89.83

Pivot:

70.75

Moving Averages:

MA(5): 73.30     MA(20): 70.61

MA(100): 73.86     MA(250): 66.48

MACD:

MACD(12,26): -0.01     Signal(12,26,9): -0.74

%K %D:

%K(14,3): 87.03     %D(3): 88.76

RSI:

RSI(14): 55.39

52-Week:

High: 85.07  Low: 55.8  Change(%): 9.3

Average Vol(K):

3-Month: 538905  10-Days 333463

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ESRX has closed below upper band by 18.4%. Bollinger Bands are 0.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-20T02:58:30-04:00
Vilas Fund, LP Q1 '18 Letter To Partners - #28 Since Inception, Long Pharma

2018-04-17T06:05:49-04:00
Fixing Drug Costs

2018-04-13T13:00:00-04:00
Health-care companies are on a deal spree and aren't likely to stop anytime soon

2018-04-12T15:14:09-04:00
Express Scripts: Heads (Cigna Buyout) Or Tails (Go Solo), Investors Can Win Either Way

2018-04-12T08:54:28-04:00
Express Scripts launches innovative pilot program for performance-based retail pharmacy network

2018-04-12T08:00:00-04:00
Express Scripts Launches Innovative Pilot Program For Performance-based Retail Pharmacy Network for Commercial Plans

2018-04-11T07:23:47-04:00
Brunch, Craft Beer, And Investing: A Turning Point

2018-04-10T08:00:00-04:00
U.S. Workers' Compensation Prescription Drug Spending Decreased 3.3 Percent in 2017

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  0

Industry:  0

Shares Out. (M)

561.53

Shares Float (M)

557.94

% Held by Insiders

0.60

% Held by Institutions

91.00

Shares Short (K)

12644

Shares Short Prior Month (K)

31570

Stock Financials

EPS

7.120

EPS Est. Current Year

7.000

EPS Est. Next Year

7.670

EPS Est. Next Quarter

1.490

Forward EPS

10.130

Book Value (p.s.)

2.220

PEG Ratio

0.65

Profit Margin

5.53

Operating Margin

5.53

Return on Assets (ttm)

8.5

Return on Equity (ttm)

26.3

Qtrly Rev. Growth

2.1

Gross Profit (p.s.)

11.169

Sales Per Share

EBITDA (p.s.)

9.411

Qtrly Earnings Growth

62.20

Operating Cash Flow (M)

5350.00

Levered Free Cash Flow (M)

5470.00

atoplab.com

Valuation

P/E

10.32

P/E Growth Ratio

P/BV

33.10

P/S

239241904.00

P/CF

7.71

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

2003-11-12

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.